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Implications of insecticide resistance for malaria vector control 
with long-lasting insecticidal nets: a WHO-coordinated, 
prospective, international, observational cohort study
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Eric Ochomo, Etienne Fondjo, Herman Parfait Awono-Ambene, Josiane Etang, Martin Akogbeto, Rajendra M Bhatt, Mehul Kumar Chourasia, 
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Jonathan Lines, Martin James Donnelly
Summary
Background Scale-up of insecticide-based interventions has averted more than 500 million malaria cases since 2000. 
Increasing insecticide resistance could herald a rebound in disease and mortality. We aimed to investigate whether 
insecticide resistance was associated with loss of effectiveness of long-lasting insecticidal nets and increased malaria 
disease burden.
Methods This WHO-coordinated, prospective, observational cohort study was done at 279 clusters (villages or groups 
of villages in which phenotypic resistance was measurable) in Benin, Cameroon, India, Kenya, and Sudan. Pyrethroid 
long-lasting insecticidal nets were the principal form of malaria vector control in all study areas; in Sudan this 
approach was supplemented by indoor residual spraying. Cohorts of children from randomly selected households in 
each cluster were recruited and followed up by community health workers to measure incidence of clinical malaria 
and prevalence of infection. Mosquitoes were assessed for susceptibility to pyrethroids using the standard WHO 
bioassay test. Country-specific results were combined using meta-analysis.
Findings Between June 2, 2012, and Nov 4, 2016, 40 000 children were enrolled and assessed for clinical incidence 
during 1·4 million follow-up visits. 80 000 mosquitoes were assessed for insecticide resistance. Long-lasting 
insecticidal net users had lower infection prevalence (adjusted odds ratio [OR] 0·63, 95% CI 0·51–0·78) and disease 
incidence (adjusted rate ratio [RR] 0·62, 0·41–0·94) than did non-users across a range of resistance levels. We found 
no evidence of an association between insecticide resistance and infection prevalence (adjusted OR 0·86, 0·70–1·06) 
or incidence (adjusted RR 0·89, 0·72–1·10). Users of nets, although significantly better protected than non-users, 
were nevertheless subject to high malaria infection risk (ranging from an average incidence in net users of 0·023, 
[95% CI 0·016–0·033] per person-year in India, to 0·80 [0·65–0·97] per person year in Kenya; and an average infection 
prevalence in net users of 0·8% [0·5–1·3] in India to an average infection prevalence of 50·8% [43·4–58·2] in Benin).
Interpretation Irrespective of resistance, populations in malaria endemic areas should continue to use long-lasting 
insecticidal nets to reduce their risk of infection. As nets provide only partial protection, the development of additional 
vector control tools should be prioritised to reduce the unacceptably high malaria burden.
Funding Bill & Melinda Gates Foundation, UK Medical Research Council, and UK Department for International 
Development.
Copyright © The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license.
Introduction
Deployment of insecticide-based interventions has been 
the principal driver of reductions in the global malaria 
burden since 2000. The massive scale-up of insecticide-
treated nets resulted in more than 50% of people in 
malaria endemic areas in sub-Saharan Africa sleeping 
under nets in 2016.1 Of 663 million clinical malaria 
cases averted in sub-Saharan Africa since 2001, 78% 
were averted thanks to the use of insecticide-treated 
nets and indoor residual spraying.2 Any loss of 
effectiveness of these interventions could therefore 
cause a catastrophic rebound in disease incidence and 
mortality.
Resistance to insecticides is widespread in anopheles 
mosquitoes in sub-Saharan Africa and India, especially 
resistance to pyrethroids, the class of insecticide used 
on all long-lasting insecticidal nets. Pyrethroids are 
increasingly less effective at killing mosquitoes3,4 and 
mathematical models predict this drop in effectiveness 
could lead to increased malaria incidence.5 However, little 
evidence has been reported of an epidemiological effect 
resulting from resistance. An often cited example of 
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insecticide resistance leading to control failure is 
KwaZulu-Natal, South Africa in the late 1990s, where 
despite good indoor residual spraying coverage, a 
ten-times increase in malaria cases was reversed 
when pyrethroid spraying was replaced with dichloro- 
diphenyltrichloroethane (DDT) spraying in response to 
reported pyrethroid resistance in a local malaria vector, 
Anopheles funestus.6 This apparent control failure was with 
indoor residual spraying, not insecticide-treated nets, and 
could have been confounded by the simul taneous 
introduction of artemether plus lumefantrine as a first-line 
treatment following reported resistance to sulfadoxine 
plus pyrimethamine. To date, no convincing examples of 
long-lasting insecticidal net malaria control failure due to 
pyrethroid resistance have been reported. Studies from 
Malawi7 and Kenya8 showed that insecticide-treated nets 
protected against malaria infection in areas with 
substantial amounts of pyrethroid resistance.
In 2012, WHO released the Global Plan for Insecticide 
Resistance Management in Malaria Vectors9 to slow the 
development of insecticide resistance. This plan has 
been a challenge for national programmes to implement 
because of its primary focus on switching chemical 
classes for indoor residual spraying.4,10
This multicountry prospective study was coordinated by 
WHO to assess the effect of insecticide resistance on 
malaria disease burden and on the performance of 
long-lasting insecticidal nets.11 We aimed to address 
two questions. First, are long-lasting insecticidal nets 
protective against malaria in the presence of vector 
resistance to pyrethroids, and second, are higher 
frequencies of vector resistance to pyrethroids associated 
with greater infection prevalence and incidence of clinical 
malaria at the community level? A third aim, to assess the 
effect on insecticide resistance of scaling-up insecticide-
based interventions, will be addressed in a separate paper.
Methods
Study design and participants
This prospective, observational cohort study was done at 
279 distinct geographical locations (subsequently referred 
to as clusters) in five countries (Benin, Cameroon, India, 
Research in context
Evidence before this study
Nearly 70% of the more than 660 million clinical cases of 
malaria that were averted between 2000 and 2015, have been 
attributed to the use of insecticide-treated nets. Therefore, to 
quantify the likely effects of emergent insecticide resistance 
on disease burden is a major public health imperative. 
We searched the PubMed database, with no date or language 
restrictions, using the terms “insecticide resistance” or 
“pyrethroid resistance”, “malaria”, “effectiveness” or “efficacy”, 
and “long lasting insecticidal net (LLIN)” or “insecticide 
treated net (ITN)”. We found a predominance of 
entomological or laboratory studies, several mathematical 
modelling studies, and a small number of studies describing 
the effect on epidemiological outcomes. All studies describing 
the effect on epidemiological outcomes were observational. 
Some studies compared malaria incidence or prevalence 
before and after long-lasting insecticidal net distribution, and 
others evaluated the effectiveness of long-lasting insecticidal 
nets in the presence of insecticide resistance in a single 
location, either through cross-sectional surveys or cohort 
follow-up. None of these studies had simultaneous 
characterisation of disease or infection burden and insecticide 
resistance. Entomological studies generally concluded that 
reduced mosquito mortality in bioassay tests and 
experimental hut studies would affect malaria control, but 
without evidence of an effect in humans. Epidemiological 
studies either found that net users were at least partly 
protected against malaria compared with non-users, even in 
the presence of resistance, or found that the effect on malaria 
after universal long-lasting insecticidal net distribution was 
suboptimal, thus concluding that this was due to 
insecticide resistance.
Added value of this study
In a WHO-coordinated initiative, we measured pyrethroid 
resistance and the effectiveness of long-lasting insecticidal 
nets concurrently in prospective studies (cohort and 
cross-sectional) in 279 locations in five countries. 
We compared effectiveness of long-lasting insecticidal nets at 
locations with differing levels of insecticide resistance. 
We showed that resistance is highly variable in time and space. 
We found that nets provided protection against malaria in 
most locations, irrespective of the presence of insecticide 
resistance. Previous studies did not compare effectiveness at 
locations that differed in resistance, and did not assess the 
effect of resistance on malaria burden in as many locations 
and settings as we did in this study.
Implications of all the available evidence
Evidence suggests that using a long-lasting insecticidal net 
provides protection against malaria, even in areas with 
pyrethroid resistance. Whether pyrethroid only long-lasting 
insecticidal nets are as effective as they were before the onset of 
resistance, and whether long-lasting insecticidal nets might 
become less effective in areas with higher amounts of resistance 
than were encountered in our study, is not known. Universal 
access to long-lasting insecticidal nets, together with 
campaigns to achieve greater use of nets, should continue in 
malaria endemic areas, even in the presence of insecticide 
resistance. However, in some locations malaria incidence 
remained high despite high use of nets, emphasising the need 
for new tools and approaches for malaria prevention if targets 
for the reduction of the global malaria burden are to be 
achieved, and to forestall a potential rebound of malaria due to 
higher resistance in the future.
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Kenya, and Sudan), representing a range of pyrethroid 
resistance and malaria transmission scenarios. Each 
cluster was a village or group of villages in which 
phenotypic resistance could be measured. The study was 
observational, as resistance cannot be randomly assigned, 
and because it is unethical to randomly allocate 
long-lasting insecticidal nets to study populations in 
malaria endemic areas.11
Insecticide resistance and malaria prevalence and 
incidence were measured over consecutive years, alongside 
each other in all study clusters to increase statistical power 
and capture variation in disease burden and effectiveness 
of nets in relation to variation in insecticide resistance 
across a wide range of locations and over time.
In each cluster, cohorts of children from randomly 
selected households were recruited and followed up by 
community health workers to measure clinical malaria 
incidence. The same cohort was followed over several 
years in four countries (Kenya: September, 2013 to 
December, 2015; India: May, 2015, to November, 2016; 
Sudan: June, 2012, to December, 2014; and Benin: 
February, 2013, to December, 2014, with a separate cohort 
from May to November, 2015), whereas in Cameroon 
cohorts were recruited for each malaria season from 
September to December each year from 2013 to 2015. In 
high transmission sites (Benin, Cameroon, and Kenya), 
children aged 6 months to 5 years were eligible for 
inclusion, in India children aged 6 months to 14 years 
were eligible, and in Sudan children aged 6 months to 
10 years were eligible. We used no other eligibility 
criteria, except that the child should be normally resident 
in the cluster.
Pyrethroid long-lasting insecticidal nets were the 
principal form of malaria vector control in all study 
areas; in Sudan this approach was supplemented by 
indoor residual spraying.12 Long-lasting insecticidal net 
effectiveness was assessed by comparing malaria 
incidence as rate ratios (RR) and prevalence as odds ratios 
(OR) between net users and non-users. Long-lasting 
insecticidal net effectiveness was compared at locations 
with differing amounts of resistance. A standardised 
study framework was applied across countries,11 but there 
were minor amendments to account for differences in 
local policy and practice.
Ethical approval was obtained from national 
ethics committees (approval numbers 102/CNE/SE/09 
[Cameroon], 116-12-09 [Sudan], SSC/ERC No. 1677 [Kenya], 
ECR/NIMR/EC/2010/75 [India], and 007 [25 May 2010] 
[Benin]). Participation in each component of the study 
was subject to written informed consent by the parent or 
guardian, and additional assent by children aged 10 years 
and older.
Procedures
Mosquitoes were collected seasonally in each cluster to 
assess susceptibility to pyrethroids. Larvae were reared 
until they were 2–5-day-old adults, and female 
mosquitoes were exposed to the discriminating dose of 
deltamethrin using the standard WHO bioassay test; in 
India it was necessary to use mixed age, wild-caught 
mosquitoes or F1 progeny for susceptibility testing.13 
Mortality was recorded 24 h after deltamethrin exposure. 
Cluster and year specific mosquito mortality 
measurements were dichotomised as either high or low 
resistance in relation to the median mortality of all 
measurements from all study clusters.
For vector control, long-lasting insecticidal net 
distributions provided coverage of one net per two people 
across all five study sites. Nets were distributed in Benin 
in 2011 (Olyset Net; Sumitomo Chemical, Tokyo, Japan; 
1 g/m² permethrin) and 2014 (PermaNet 2.0; Vestergaard, 
Lausanne, Switzerland; 55 mg/m² deltamethrin), in 
Cameroon in 2011 and 2015 (PermaNet 2.0), in India in 
2014 (PermaNet 2.0), in Kenya in 2012 and 2014 (Olyset 
Net), and in Sudan in 2011 and 2014 (PermaNet 2.0). In 
Sudan, half of the clusters were randomised to receive 
two rounds of indoor residual spraying with bendiocarb 
(Ficam 80% wettable powder; Bayer, Leverkusen, 
Germany; 200 mg active ingredient per m²) each year, 
except for a small number of indoor residual spraying 
clusters that were sprayed with two rounds of 
deltamethrin (Chema Industries, Alexandria, Egypt; 
25 mg active ingredient per m²) in 2012.12
For active case detection, each child was visited 
regularly (fortnightly in Cameroon, Sudan, and India, 
and monthly in Benin and Kenya). Those with an axillary 
temperature greater than 37·5°C or reporting fever in the 
previous 2 weeks were tested using a rapid diagnostic 
test (in Cameroon, India, Kenya, and Sudan; CareStart 
Malaria HRP2 [Pf ]; Access Bio, Somerset, NJ, USA [used 
in Kenya and Cameroon]; SD Bioline Malaria Ag P.f/Pan; 
Standard Diagnostics, Gyeonggi-do, South Korea [used 
in Kenya and Sudan]; and SD Bioline Malaria, Alere 
Medical, Gurgaon, India [used in India]) or microscopy 
(in Benin). Children who tested positive were treated 
according to national guidelines or were referred to a 
health facility. If caregivers reported upon questioning 
that a child had visited a health facility since the last visit, 
the community health workers recorded confirmed 
malaria diagnoses from health facility records. An adult 
caregiver was asked whether the child slept under a long-
lasting insecticidal net the night before each visit, except 
in Cameroon where net use was an inclusion criterion. 
Children who reached the upper age limit of eligibility 
were excluded from further assessments and replaced 
by a younger child, usually a sibling from the same 
household.
Cross-sectional surveys were done to measure 
infection prevalence during the transmission season 
(Benin in July, 2015; Cameroon in October, 2013, and 
October, 2014; Kenya in December, 2012, and 
December, 2014; India in August, 2015, and June and 
November, 2016; and Sudan in September of 2012, 2013, 
and 2014). In Benin, Cameroon, and Kenya, households 
Articles
www.thelancet.com/infection   Vol 18   June 2018 643
were randomly selected from lists prepared for each 
cluster. In Sudan, a random subset of the cohort was 
selected, whereas in India the entire cohort was 
included. Participating children were tested for malaria 
parasites and the caregiver was asked whether the child 
slept under a long-lasting insecticidal net the night 
before the survey.
Slides were read by two trained microscopists for 
results in both cohort and cross-sectional studies. 
Discordance was settled by a third reader.
Statistical analysis
Sample size was determined separately for each country11 
to provide 80% power to detect minimum differences 
in clinical incidence ranging from 30% (Sudan) to 
54% (Benin) between high and low resistance clusters. 
When the results of the five countries were combined, there 
was 80% power to detect a 15% difference in malaria 
incidence between high and low resistance clusters, 
assuming a coefficient of variation between clusters of 0·45.
Malaria incidence was estimated as the number of 
incident cases per child-year of follow-up. Consecutive 
positive test results were counted as one episode because 
the second positive test could be a false positive from 
rapid detection tests that detect retained parasite antigen 
from an already cleared infection. A child was considered 
not at risk for a period of 2 weeks after a positive test 
result because of the prophylactic effect of treatment. 
Follow-up was censored for periods when a child was 
absent. Each year’s follow-up was linked with the 
mosquito mortality measurement taken in that cluster 
for that year. For cohorts that continued for more 
than 1 year, follow-up was split into calendar years. 
For Benin in 2013, where bioassays were done in June, 
insecticide resistance measurements were assigned to 
follow-up from January to July, and for bioassays done in 
October, insecticide resistance measurements were 
assigned to follow-up from August to December. 
For India, where mosquito mortality was measured in 
December, 2015, resistance measurements were related 
to follow-up data from May, 2015, to June, 2016, and for 
mosquito mortality measurements in December, 2016, 
resistance measurements were related to follow-up data 
from July, 2016, to December, 2016. We used RRs 
to compare incidence during follow-up stratified by 
reported long-lasting insecticidal net use. We compared 
incidence RRs for long-lasting insecticidal net use versus 
non-use between areas of high and low resistance 
(interaction test) using Poisson regression adjusted for 
age, district, calendar month, and in the case of Sudan, 
indoor residual spraying. We used random effects meta-
analysis to compute the overall RRs of effectiveness of 
long-lasting insecticidal nets for high and low resistance 
strata, for all countries combined, and separately for all 
countries, excluding Sudan. Results were displayed as 
forest plots. Results are presented with and without 
Sudanese data because it was the only country in which 
indoor residual spraying was used in addition to 
long-lasting insecticidal nets, and where net use 
was positively associated with malaria incidence 
and prevalence.
In separate Poisson regression models, we investigated 
the effect of insecticide resistance on case incidence. We 
used RRs to compare high and low insecticide resistance 
Benin Cameroon Kenya India Sudan
Study locations Districts of Ifangni, Sakété, 
Pobé, and Kétou 
(Departement de Plateau)
Districts of Garoua, Pitoa, 
and Mayo Oulo 
(north region)
Districts of Teso, Rachuonyo, Nyando, 
and Bondo (western Kenya)
Subdistrict of Keshkal 
(Kondagaon, Chhattisgarh)
El Hoosh and Hag Abdalla 
(Gezira state); Galabat (Gedarif state); 
New Halfa (Kassala state)
Study clusters 32 38 50 80 79
Predominant malaria 
vectors
Anopheles gambiae 
subspecies and 
Anopheles colluzzii
Anopheles arabiensis, 
A gambiae subspecies, 
and Anopheles funestus
A gambiae subspecies, A arabiensis, 
and A funestus
Anopheles culicifacies A arabiensis
Vector control 
interventions
High coverage of 
insecticide-treated nets 
(primarily PermaNet 2.0) 
in all clusters
High coverage of 
insecticide-treated nets 
(PermaNet 2.0) in all 
clusters
High coverage of insecticide-treated 
nets (PermaNet 2.0 and Olyset Net) in 
all clusters; Rachuonyo and Nyando 
received indoor residual spraying with 
deltamethrin and λ-cyhalothrin in 
2012, but no indoor residual spraying 
was done subsequently
High coverage of 
insecticide-treated nets 
(PermaNet 2.0) in all clusters
High coverage of insecticide-treated 
nets (PermaNet 2.0) in all study 
clusters; in each study area, half of 
clusters were randomly allocated to 
receive additional indoor residual 
spraying with bendiocarb, balanced 
by baseline kdr frequencies
Baseline insecticide 
resistance 
(cluster-specific range)
kdr frequency by cluster 
ranged from 44–93% (2011); 
WHO bioassay mortality to 
deltamethrin ranged from 
20–100% (2011)
kdr frequency by cluster 
ranged from 9–65% (2011); 
WHO bioassay mortality to 
deltamethrin ranged from 
43–100% (2012)
WHO bioassay mortality to 
deltamethrin ranged from 
1–100% (2011)
WHO bioassay mortality to 
deltamethrin ranged from 
86–100% in 2013
kdr frequency by cluster ranged from 
8·3–70·8% (2010); WHO bioassay 
mortality to deltamethrin in sentinel 
clusters ranged from 47–100% (2011)
PfPR2–10 endemicity 
class*
High High High Low Low
Unless otherwise indicated there was no contemporaneous indoor residual spraying done in the study areas. *PfPR2–10 is the proportion of children aged 2–10 years in the general population who are infected with 
Plasmodium falciparum, averaged over the 12 months of 2010 as estimated by Malaria Atlas Project (MAP);16 low PfPR2–10 is 0% to ≤5%, intermediate PfPR2–10 is >5% to ≤40%, and high PfPR2–10 is >40%. 
kdr=knockdown resistance.
Table 1: Study setting characteristics by country
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clusters, dichotomised as either high or low resistance in 
relation to the median mortality of all measurements 
from all study clusters. The incidence RR per 
10% decrease in mosquito mortality was calculated 
similarly using resistance as a continuous variable. RRs 
and interaction tests were adjusted for age, district, 
long-lasting insecticidal net use, and calendar month, 
and indoor residual spraying in the case of Sudan.
Prevalence of infection was calculated as the number 
of people who tested positively divided by the total 
number tested in cross-sectional surveys. Analyses 
analogous to those described above were done for cross-
sectional prevalence data using logistic regression to 
estimate ORs, comparing prevalence of infection 
between those reporting long-lasting insecticidal net 
use the night before the survey, and those reporting not 
to have used a net. We compared ORs for net use versus 
non-use between areas of high and low resistance using 
logistic regression adjusted for age, district, and in the 
case of Sudan, indoor residual spraying. We used 
random effects  meta analysis to compute the overall 
ORs of effectiveness of long-lasting insecticidal nets for 
high and low resistance strata for all countries 
combined, and separately for all countries, excluding 
Sudan.
In separate logistic regression models, we investigated 
the effect of insecticide resistance on infection prevalence. 
We used ORs to compare high and low resistance clusters, 
dichotimised in relation to the median mortality of all 
measurements from all study clusters. The OR per 10% 
decrease in mosquito mortality was calculated using 
resistance as a continuous variable.
We produced cluster level standardised prevalence 
residuals by subtracting the survey mean and dividing by 
the survey SD. Cluster level standardised incidence 
residuals were calculated similarly. We created scatter 
plots of standardised prevalence and incidence against 
mosquito mortality.
In India, a socioeconomic status variable was calculated 
for each study participant, based on occupation, education, 
and income of the head of household.14 Socioeconomic 
status was included in separate models of incidence and 
prevalence and net use for India to investigate whether 
this variable confounded the relationship between malaria 
and net use.
In all statistical models, we used generalised 
estimating equations15 and robust standard errors to 
account for intracluster correlation of responses 
(appendix, pp 1–2). Statistical analysis was done using 
Stata 14.2.
Role of the funding source
The funder had no role in the study design, data 
collection, data analysis, data interpretation, or writing of 
the report. The corresponding author had full access to 
the study data and had final responsibility for the decision 
to submit for publication.
Results
Between June 2, 2012, and Nov 4, 2016, 40 251 children 
were enrolled and assessed for clinical incidence during 
1·4 million follow-up visits. About 65 000 mosquitoes 
were assessed for insecticide resistance. 681 bioassay 
measurements were done between Aug 9, 2011, and 
Sept 16, 2016, at the 279 distinct geographical clusters.
Details of study settings, predominant vector species, 
malaria endemicity, and long-lasting insecticidal net use in 
each country were summarised (table 1; appendix p 3). 
Median cluster-level bioassay mortality was 78·6% (IQR 
58·0–92·0), with considerable variation between clusters, 
countries, and years (table 2). In 78% of bioassay 
measurements mortality was less than 90%.
wSleeping under a long-lasting insecticidal net was 
associated with lower clinical malaria incidence (table 3). 
When Sudan was excluded, the protective effect of nets 
was greater than the overall estimate. In Sudan, there was 
weak evidence of long-lasting insecticidal net use being 
associated with higher malaria incidence (RR 1·33, 95% CI 
0·97–1·82). Dichotomising cluster–time instances by 
median mosquito mortality showed no evidence that the 
effect of nets differed between high and low resistance 
clusters, whether Sudan was excluded or included (table 3).
We found no evidence that clinical incidence differed 
between high and low resistance clusters for all locations 
Mosquitoes 
tested
Median (range) cluster 
level mosquito 
mortality*
Benin (Anopheles gambiae sensu lato)
2013 4756 95% (61–100) [91–99]
2014 2433 47% (19–73) [38–56]
2015 1580 55% (19–85) [47–69]
Cameroon (Anopheles gambiae sensu lato)
2013 2248 79% (27–100) [51–90]
2014 2572 74% (20–99) [52–86]
2015 2945 62% (25–93) [44–77]
Kenya (Anopheles gambiae sensu lato)
2012 1523 77% (10–100) [65–83]
2013 3333 87% (56–100) [81–97]
2014 4896 68% (4–97) [42–81]
2015 4692 71% (15–100) [46–90]
Sudan (Anopheles arabiensis)
2012 4238 73% (30–100) [61–82]
2013 6450 80% (43–100) [66–89]
2014 6080 51% (3–90) [35–67]
India (Anopheles culicifacies sensu lato)
2015 8112 84% (57–100) [73–96]
2016 8316 96% (77–100) [92–98]
All bioassays combined 64 174 79% (3–100) [58–92]
Predominant vectors are shown in parentheses next to countries. *IQRs are 
indicated in square brackets.
Table 2: Insecticide resistance by year
See Online for appendix
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and timepoints combined (table 3). We found evidence of 
a negative linear association between incidence and 
mosquito mortality (table 3; figure). After removing four 
outliers (defined as points whose standardised values 
were >4 SDs above the mean value) this association was 
not significant (table 3).
Net users had a significantly lower risk of infection for 
all countries combined (table 4). However, for Sudan we 
found little evidence of a protective effect of net use 
(table 4; appendix p 7). Stratifying clusters into high and 
low resistance showed nearly identical effectiveness of 
nets across the two strata, and this result was similar 
when excluding Sudan (table 4).
In separate analyses, restricting the analysis to cluster-
time instances in which mosquito mortality was less 
then 50%, we found evidence that nets provided 
protection against infection, but there was no evidence 
that they provide protection against clinical malaria 
(appendix pp 10–13).
We noted no association between human infection 
prevalence and lower mosquito bioassay mortality. 
Prevalence declined with decreasing mosquito mortality 
when resistance was modelled as a continuous variable 
(table 4; figure). After removing eight outliers (as defined 
previously) we found no evidence for an association 
between prevalence and mosquito mortality (table 4).
For Indian incidence data, the RR for net use without 
adjusting for socioeconomic status was 0·31 (95% CI 
0·22–42, p<0·0001), and the RR for net use adjusted for 
socioeconomic status was 0·30 (0·22–0·42, p<0·0001). 
For prevalence, the OR before adjusting for socioeconomic 
status (0·35, 0·23–0·53, p<0·0001) was similar to that 
after adjusting for socioeconomic status (0·35, 0·23–0·52, 
p<0·0001). The mean difference in age between net users 
and non-users, adjusted for country, was 0·04 years 
(p=0·170).
Discussion
Our study found that long-lasting insecticidal nets 
provided protection against malaria in all study 
countries except Sudan, despite vector resistance. 
We found no evidence that the amount of protection 
provided by long-lasting insecticidal nets differed by the 
frequency of resistance as measured by WHO bioassays. 
Similarly, we found no evidence of an association 
between infection prevalence or clinical incidence with 
higher pyrethroid resistance.
A Cochrane review17 of trials that preceded widespread 
emergence of pyrethroid resistance provided overall 
estimates of effectiveness of insecticide-treated nets that 
were similar to the estimates of effectiveness made in 
our study (13% for parasite prevalence and 50% for 
uncomplicated malaria incidence). However, several 
factors should be taken into account when comparing 
our results with those of the Cochrane review. First, our 
study did not test if protection provided before the 
emergence of resistance was the same as that observed 
after resistance emerged. Second, the measure of 
effectiveness in our study was based on comparing net 
users with non-users, whereas trials included in the 
Cochrane review compared communities that were 
randomised to receive nets or not. Third, the trials 
included in the Cochrane review were conducted at a 
time when most settings had higher intensity of malaria 
transmission than those encountered in our study 
settings, which is likely to affect observed effectiveness.
A 2014 meta-analysis18 found that treated nets offered 
greater protection than did untreated nets, even when 
vectors were resistant to pyrethroids. Another study19 
showed that oocyst development was slower in 
deltamethrin-exposed plasmodium-infected resistant 
mosquitoes compared with unexposed individuals. A 
further study20 found delayed mortality despite initial 
survival beyond 24 h following exposure to insecticide on 
long-lasting insecticidal nets in highly pyrethroid-resistant 
malaria vectors. Therefore, plausible mechanisms are 
Figure: Association between mosquito mortality and malaria burden at the cluster level
(A) Clinical malaria incidence and (B) prevalence of malaria infection. The line represents the regression line and the 
shaded area is the 95% CI.
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present through which long-lasting insecticidal nets 
might continue to provide at least partial protection 
against malaria, despite vector resistance.21,22
The average daily survival of mosquitoes encountering 
treated nets should be substantially reduced with high 
long-lasting insecticidal net coverage and susceptible 
mosquitoes, resulting in a mass effect of long-lasting 
insecticidal nets reducing the risk of infective bites for 
users and non-users alike.23 If mosquitoes are resistant to 
pyrethroids, the contact irritancy and physical barrier of 
long-lasting insecticidal nets is likely to provide users 
with some protection against resistant mosquitoes 
seeking a blood meal,24 but the mass effect could 
diminish. Because of diversion, the risk of infection for 
non-users of long-lasting insecticidal nets could increase, 
whereas the risk for users could remain relatively 
unchanged. Measuring the community effect of long-
lasting insecticidal nets on malaria transmission would 
require random assignment of communities to receive 
or not receive nets, which is unethical in malaria-
endemic areas. However, infection rates were higher in 
non-users than users, even in communities with high 
proportions of reported net use, suggesting that nets 
might have provided no community protection. 
Pyrethroid resistance might have reduced the mass effect 
of long-lasting insecticidal nets, even if there was little or 
no measurable effect on personal protection.
Our study has several limitations. Insecticide resistance 
measurement was based on the WHO insecticide 
susceptibility test using a diagnostic dose, which 
measures the frequency of resistant individuals in the 
mosquito population, but not the intensity or strength of 
resistance in those individuals. Measures of resistance 
intensity based on a dose-response relationship25 would 
have been more informative, but for our study the 
standard WHO bioassay test was considered best suited 
for the scale and variety of settings in which insecticide 
susceptibility status had to be assessed. A reduction in 
vector control effectiveness that was not detected might 
have occurred in this evaluation. Resistance to pyrethroids 
(by WHO definition mortality <90%13) was observed in 
78% of study clusters. Therefore, resistance might have 
an impact on malaria prevalence and incidence across all 
study clusters, but the paucity of susceptible mosquito 
populations (ie, ≥98% mortality) might have rendered 
any impact undetectable. Conversely, resistance intensity 
might not have reached a level that resulted in a detectable 
epidemiological effect. However, post-hoc analysis 
restricted to clusters with less than 50% bioassay mortality 
showed that long-lasting insecticidal nets still offered 
protection from malaria infection.
Because it is not possible to randomise locations to 
insecticide resistance or ethical to randomise children to 
not use nets, our study had to rely on an observational 
design, rendering it subject to confounding factors. In 
Sudan, we observed higher clinical incidence with net 
use than non-net use. This association is more likely to 
be due to those who are at higher risk of mosquito bites 
being more likely to use nets,1 rather than the implausible 
explanation that use of nets increased the risk of malaria 
infection in this setting. The observed protective effect of 
long-lasting insecticidal nets in the other four countries 
could have been exaggerated because of socioeconomic 
differences between users and non-users.26 The scale of 
our study precluded measurement of socioeconomic 
status for all children. However, in Benin27 and India 
where socioeconomic status was measured, the protective 
effect of nets persisted after adjusting for this factor.
Our large multicountry study found that pyrethroid 
long-lasting insecticidal nets protect against malaria 
despite vector resistance.28 Whatever the explanation, our 
results provide evidence to suggest that, regardless of 
insecticide resistance, populations living in malaria-
endemic areas should continue to use long-lasting 
insecticidal nets, as this will reduce their chances of 
malaria infection and disease. Nevertheless, standard 
nets provide only partial protection against malaria, and 
therefore the integration of novel technologies and 
approaches, and new tools including new generation 
nets, will be essential to achieve the targets set out in the 
Global Technical Strategy for Malaria 2016–2030.29 
Resistance of malaria vectors to insecticides—particularly 
pyrethroids—is increasing in intensity and geographical 
spread,3 and is more pronounced in countries other than 
where our study sites were located.30 Entomological data 
suggest reduced bednet efficacy in these locations with 
high resistance intensity.31 Resources should be mobilised 
to enable countries to develop and implement insecticide 
resistance management plans9 and to support 
development of additional vector control strategies. In 
the interim, efforts should be made to increase access to 
good condition long-lasting insecticidal nets. Use of 
pyrethroid nets will continue to save lives until more 
effective malaria prevention methods are available.
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